NO952205D0 - Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter - Google Patents
Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenterInfo
- Publication number
- NO952205D0 NO952205D0 NO952205A NO952205A NO952205D0 NO 952205 D0 NO952205 D0 NO 952205D0 NO 952205 A NO952205 A NO 952205A NO 952205 A NO952205 A NO 952205A NO 952205 D0 NO952205 D0 NO 952205D0
- Authority
- NO
- Norway
- Prior art keywords
- medicaments
- preparation
- heterocyclic carbamates
- carbamates
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4333761A DE4333761A1 (de) | 1993-10-04 | 1993-10-04 | Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel |
| PCT/EP1994/003280 WO1995009842A1 (en) | 1993-10-04 | 1994-10-04 | Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952205D0 true NO952205D0 (no) | 1995-06-02 |
| NO952205L NO952205L (no) | 1995-06-02 |
Family
ID=6499349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952205A NO952205L (no) | 1993-10-04 | 1995-06-02 | Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5679677A (no) |
| EP (1) | EP0649839A1 (no) |
| JP (1) | JPH08504216A (no) |
| AU (1) | AU684314B2 (no) |
| CA (1) | CA2148361A1 (no) |
| DE (2) | DE4345266C2 (no) |
| FI (1) | FI952324A (no) |
| NO (1) | NO952205L (no) |
| WO (1) | WO1995009842A1 (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7261742B2 (en) * | 2005-10-13 | 2007-08-28 | S.C. Johnson & Son, Inc. | Method of deodorizing a textile |
| US7407922B2 (en) * | 2005-10-13 | 2008-08-05 | S.C. Johnson & Son, Inc. | Deodorizing compositions |
| CA2659967C (en) * | 2006-08-08 | 2014-05-13 | Aska Pharmaceutical Co., Ltd. | Quinazoline derivatives |
| US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| EA019833B1 (ru) | 2007-01-22 | 2014-06-30 | ДЖиТиЭкс, ИНК. | Вещества, связывающие ядерные рецепторы |
| EP2124562B1 (en) | 2007-03-09 | 2016-04-20 | Second Genome, Inc. | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| EP2585066B1 (en) * | 2010-06-24 | 2018-09-26 | Alkermes Pharma Ireland Limited | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| CA2816022C (en) | 2010-10-29 | 2019-09-10 | Emory University | Quinazoline derivatives, compositions, and uses related thereto |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| EA201690713A1 (ru) | 2013-10-04 | 2016-08-31 | Инфинити Фармасьютикалз, Инк. | Гетероциклические соединения и их применения |
| US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| CA2943075C (en) | 2014-03-19 | 2023-02-28 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
| US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
| NZ740616A (en) | 2015-09-14 | 2023-05-26 | Infinity Pharmaceuticals Inc | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same |
| WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
| WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE36226B1 (en) * | 1935-11-11 | 1976-09-15 | Shimamoto Takio | Phthalazone derivatives |
| FR1460552A (fr) * | 1965-04-22 | 1966-03-04 | Agripat Sa | Additifs à des nourritures pour animaux |
| NL6702189A (no) * | 1967-02-14 | 1968-08-15 | ||
| DE1807685A1 (de) * | 1968-11-08 | 1970-08-06 | Chinoin Gyogyszer Es Vegyeszet | Neue Chinazolon-Derivate und Verfahren zur Herstellung derselben |
| CH540266A (de) * | 1968-12-04 | 1973-08-15 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von Chinazolon-Derivaten |
| JPS5418270B2 (no) * | 1971-12-06 | 1979-07-06 | ||
| AR205004A1 (es) * | 1973-10-30 | 1976-03-31 | Ishikawa M | Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona |
| US4293553A (en) * | 1978-08-11 | 1981-10-06 | Masayuki Ishikawa | 1-Phthalazone derivatives, and use thereof |
| JPS5976069A (ja) * | 1982-10-25 | 1984-04-28 | Showa Denko Kk | フタラゾン誘導体 |
| GB2127805A (en) * | 1982-09-13 | 1984-04-18 | Showa Denko Kk | Phthalazones |
| US4769367A (en) * | 1984-04-24 | 1988-09-06 | Glaxo Group Limited | Heterocyclic amino compounds |
-
1993
- 1993-10-04 DE DE4345266A patent/DE4345266C2/de not_active Expired - Fee Related
- 1993-10-04 DE DE4333761A patent/DE4333761A1/de not_active Withdrawn
-
1994
- 1994-10-04 AU AU77845/94A patent/AU684314B2/en not_active Ceased
- 1994-10-04 EP EP94115598A patent/EP0649839A1/en not_active Withdrawn
- 1994-10-04 JP JP7510611A patent/JPH08504216A/ja active Pending
- 1994-10-04 US US08/446,867 patent/US5679677A/en not_active Expired - Fee Related
- 1994-10-04 CA CA002148361A patent/CA2148361A1/en not_active Abandoned
- 1994-10-04 WO PCT/EP1994/003280 patent/WO1995009842A1/en active Application Filing
-
1995
- 1995-05-12 FI FI952324A patent/FI952324A/fi unknown
- 1995-06-02 NO NO952205A patent/NO952205L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE4345266A1 (de) | 1995-06-29 |
| FI952324A0 (fi) | 1995-05-12 |
| US5679677A (en) | 1997-10-21 |
| FI952324A (fi) | 1995-05-12 |
| AU7784594A (en) | 1995-05-01 |
| CA2148361A1 (en) | 1995-04-13 |
| WO1995009842A1 (en) | 1995-04-13 |
| DE4333761A1 (de) | 1995-04-06 |
| EP0649839A1 (en) | 1995-04-26 |
| AU684314B2 (en) | 1997-12-11 |
| JPH08504216A (ja) | 1996-05-07 |
| DE4345266C2 (de) | 1996-12-19 |
| NO952205L (no) | 1995-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS3720A7 (is) | Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun | |
| NO940825D0 (no) | 2-Debenzoyl-2-acyltaxolderivater og fremgangsmåter ved fremstilling derav | |
| NO961425D0 (no) | 1N-alkyl-N-arylpyrimidinaminer og derivater derav | |
| NO170626C (no) | Ildsikkert, vannfast og syrebestandig produkt | |
| DK0734260T4 (da) | Paroxetintabletter og fremgangsmåde til fremstilling deraf | |
| NO307707B1 (no) | Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav | |
| NO973836D0 (no) | Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav | |
| NO952205D0 (no) | Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter | |
| NO307092B1 (no) | Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding | |
| NO932915D0 (no) | Mikroporoest krystallinsk silikoaluminofosfat og fremgangsmaate for fremstilling av dette | |
| NO932120D0 (no) | Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
| DK0540609T3 (da) | Cephalosporiner og homologer, fremstillinger og farmaceutiske præparater | |
| NO912344D0 (no) | Benzopuranderivater og heterocykliske derivater derav. | |
| NO943794D0 (no) | 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling | |
| NO961000D0 (no) | Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike | |
| HU9202864D0 (en) | Gycinamide derivatives, their production and pharmaceutical preparatives containing them | |
| NO972449D0 (no) | Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on 1,1 dioksidderivater og preparater og fremgangsmåte for anvendelse derav | |
| NO941517L (no) | 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse | |
| NO940130D0 (no) | Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav | |
| FI955605A0 (fi) | Aryloivia lääkkeitä | |
| DK0492667T3 (da) | 1,4-Benzothiazin-2-eddikesyrederivater, fremgangsmåder til fremstilling deraf og anvendelse deraf | |
| NO912946D0 (no) | P-acylaminofenoksikarbamater og derivater. | |
| NO900252D0 (no) | Cefasporinderivater og fremgangsmaate for fremstilling derav. | |
| NO943826D0 (no) | Heteroarylpiperidiner, fremgangsmåte for fremstilling og farmasöytiske blandinger hvor de er tilstede | |
| DE68921055T2 (de) | Filmstreifenschutzverfahren und -erzeugnis. |